Rituximab/Bendamustine treatment of chronic lymphatic leukemia leads to sustained remission of antiphospholipid antibodies.
作者信息
Ames Paul Rj, Merashli Mira, Gentile Fabrizio
机构信息
Immune Response and Vascular Disease Unit, Nova University, Lisbon, Portugal.
Department of Haematology, Dumfries Royal Infirmary, Scotland, UK.
出版信息
Eur J Immunol. 2019 Jun;49(6):969-970. doi: 10.1002/eji.201848042. Epub 2019 May 14.
PMID:30893471
Abstract
摘要
Zotero 插件